Immunity to human endogenous retroviruses by Nixon, Douglas F
ORAL PRESENTATION Open Access
Immunity to human endogenous retroviruses
Douglas F Nixon
From Frontiers of Retrovirology 2011
Amsterdam, The Netherlands. 3-5 October 2011
Human endogenous retroelements (which rely on an
RNA intermediate before integration into the genome)
can be classified into the non-long terminal repeat
(LTR) class and the LTR class, represented by human
endogenous retroviruses (HERV). Many HERV entered
the primate germ line as infectious retroviruses at sev-
eral time points during human evolution. Out of the six
HERVsuperfamilies, HERV-K ( H M L - 2 )i sc o n s i d e r e dt o
be the youngest and most transcriptionally active. Var-
ious studies have identified adaptive immune responses
to HERV under certain disease conditions, but whether
these represent beneficial or deleterious immune
responses is unclear. We have focused on the study of
adaptive immunity to HERV in the context of HIV
infection, and will present data on the cell mediated and
humoral responses to certain HERV families. We find
that HERV specific T cell responses can be found at
high frequency in certain HIV infected subjects, and
specific antibody responses are also identified. The func-
tional activities of these adaptive immune mechanisms
may play a role in HIV pathogenesis.
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